REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 151 filers reported holding REVOLUTION MEDICINES INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,087,270 | -19.4% | 256,043 | -22.1% | 0.00% | -25.0% |
| Q2 2023 | $8,791,067 | +7.8% | 328,638 | -12.7% | 0.00% | +33.3% |
| Q1 2023 | $8,153,907 | +58.2% | 376,450 | +74.0% | 0.00% | +50.0% |
| Q4 2022 | $5,154,648 | +2.8% | 216,400 | -14.9% | 0.00% | 0.0% |
| Q3 2022 | $5,014,000 | +30.4% | 254,262 | +28.9% | 0.00% | 0.0% |
| Q2 2022 | $3,845,000 | -33.2% | 197,297 | -12.6% | 0.00% | 0.0% |
| Q1 2022 | $5,757,000 | +116.7% | 225,668 | +113.7% | 0.00% | +100.0% |
| Q4 2021 | $2,657,000 | +12.2% | 105,582 | +22.6% | 0.00% | 0.0% |
| Q3 2021 | $2,369,000 | +12.9% | 86,100 | +30.3% | 0.00% | 0.0% |
| Q2 2021 | $2,098,000 | -20.0% | 66,100 | +15.6% | 0.00% | 0.0% |
| Q1 2021 | $2,624,000 | +17.7% | 57,200 | +1.6% | 0.00% | 0.0% |
| Q4 2020 | $2,229,000 | +14.6% | 56,300 | +0.7% | 0.00% | 0.0% |
| Q3 2020 | $1,945,000 | +178.3% | 55,900 | +152.6% | 0.00% | – |
| Q2 2020 | $699,000 | – | 22,127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |